The Utility of ChatGPT in Diabetic Retinopathy Risk Assessment: A Comparative Study with Clinical Diagnosis

References

• Ong KL, Stafford LK, McLaughlin SA, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;2023:1.
   Google Scholar
• Raman R, Vasconcelos JC, Rajalakshmi R, et al. Prevalence of diabetic retinopathy in India stratified by known and undiagnosed diabetes, urban–rural locations, and socioeconomic indices: results from the SMART India population-based cross-sectional screening study. Lancet Glob Health. 2022;10(12):e1764–e1773. doi:10.1016/S2214-109X(22)00411-9
   PubMed Web of Science ®Google Scholar
• Teo ZL, Tham YC, Yu M, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021;128(11):1580–1591. doi:10.1016/j.ophtha.2021.04.027
   PubMed Web of Science ®Google Scholar
• Kumar S, Mohanraj R, Raman R, et al. ‘I don't need an eye check-up’. A qualitative study using a behavioural model to understand treatment-seeking behaviour of patients with sight threatening diabetic retinopathy (STDR) in India. PLoS One. 2023;18(6):e0270562. doi:10.1371/journal.pone.0270562
   PubMed Web of Science ®Google Scholar
• Owusu-Afriyie B, Gende T, Tapilas M, Zimbare N, Kewande J. Patients’ perspective on barriers to utilization of a diabetic retinopathy screening service. Diabetology. 2023;4(3):393–405. doi:10.3390/diabetology4030033
   Google Scholar
• Liew G, Michaelides M, Bunce C. A comparison of the causes of blindness certifications in England and Wales in working age adults (16–64 years), 1999–2000 with 2009–2010. BMJ Open. 2014;4(2):e004015. doi:10.1136/bmjopen-2013-004015
   PubMed Web of Science ®Google Scholar
• DiGiorgio AM, Ehrenfeld JM. Artificial intelligence in medicine & ChatGPT: de-tether the physician. J Med Syst. 2023;47(1):32. doi:10.1007/s10916-023-01926-3
   PubMed Web of Science ®Google Scholar
• Cascella M, Montomoli J, Bellini V, Bignami E. Evaluating the feasibility of ChatGPT in healthcare: an analysis of multiple clinical and research scenarios. J Med Syst. 2023;47(1):33. doi:10.1007/s10916-023-01925-4
   PubMed Web of Science ®Google Scholar
• Fenner BJ, Wong RL, Lam WC, Tan GS, Cheung GC. Advances in retinal imaging and applications in diabetic retinopathy screening: a review. Ophthalmol Ther. 2018;7:333–346. doi:10.1007/s40123-018-0153-7
   PubMed Web of Science ®Google Scholar
• Bhargava M, Cheung CY, Sabanayagam C, et al. Accuracy of diabetic retinopathy screening by trained non-physician graders using non-mydriatic fundus camera. Singapore Med J. 2012;53(11):715.
   PubMed Web of Science ®Google Scholar
• Brzezicki MA, Bridger NE, Kobetić MD, et al. Artificial intelligence outperforms human students in conducting neurosurgical audits. Clin Neurol Neurosurg. 2020;192:105732. doi:10.1016/j.clineuro.2020.105732
   PubMed Web of Science ®Google Scholar
• Biswas SS. Role of chat gpt in public health. Ann Biomed Eng. 2023;51(5):868–869. doi:10.1007/s10439-023-03172-7
   PubMed Web of Science ®Google Scholar
• Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–163. doi:10.1016/j.jcm.2016.02.012
   PubMed Web of Science ®Google Scholar
• McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22(3):276–282. doi:10.11613/BM.2012.031
   PubMed Web of Science ®Google Scholar
• Trevethan R. Sensitivity, specificity, and predictive values: foundations, pliabilities, and pitfalls in research and practice. Front Public Health. 2017;5:307. doi:10.3389/fpubh.2017.00307
   PubMed Web of Science ®Google Scholar
• Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J. 2019;6(2):94. doi:10.7861/futurehosp.6-2-94
   PubMedGoogle Scholar
• Sarraju A, Bruemmer D, Van Iterson E, Cho L, Rodriguez F, Laffin L. Appropriateness of cardiovascular disease prevention recommendations obtained from a popular online chat-based artificial intelligence model. JAMA. 2023;329(10):842–844. doi:10.1001/jama.2023.1044
   PubMed Web of Science ®Google Scholar
• Uy H, Fielding C, Hohlfeld A, et al. Diagnostic test accuracy of artificial intelligence in screening for referable diabetic retinopathy in real-world settings: a systematic review and meta-analysis. PLOS Global Public Health. 2023;3(9):e0002160. doi:10.1371/journal.pgph.0002160
   PubMedGoogle Scholar
• Were MC. Challenges in digital medicine applications in under-resourced settings. Nat Commun. 2022; 13:3020 (2022). doi:10.1038/s41467-022-30728-3
   Web of Science ®Google Scholar
• Javaid M, Haleem A, Singh RP. ChatGPT for healthcare services: an emerging stage for an innovative perspective. BenchCouncil Trans Benchmarks Stand Eval. 2023;3(1):100105. doi:10.1016/j.tbench.2023.100105
   Google Scholar
• Jenkins AJ, Joglekar MV, Hardikar AA, Keech AC, O’Neal DN, Januszewski AS. Biomarkers in diabetic retinopathy. The review of diabetic studies. Rev Diabet Stud. 2015;12(1–2):159. doi:10.1900/RDS.2015.12.159
   PubMedGoogle Scholar
• Virgili G, Menchini F, Casazza G, et al. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst Rev. 2015;1. doi:10.1002/14651858.CD008081.pub3
   PubMedGoogle Scholar
• Prescott G, Sharp P, Goatman K, et al. Improving the cost-effectiveness of photographic screening for diabetic macular oedema: a prospective, multi-centre, UK study. Br J Ophthalmol. 2014;98(8):1042–1049. doi:10.1136/bjophthalmol-2013-304338
   PubMed Web of Science ®Google Scholar
• Priyanshu A, Vijay S, Kumar A, Naidu R, Mireshghallah F. Are chatbots ready for privacy-sensitive applications? An investigation into input regurgitation and prompt-induced sanitization. arXiv Preprint. 2023;2023:1.
   Google Scholar